Cargando…
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis
BACKGROUND: Antiepidermal growth factor receptor (EGFR)-targeted therapy is widely used in many epithelial cancer types. We investigated lapatinib effects on cutaneous squamous cell carcinoma (cSCC) scheduled for resection and in coexisting precursor lesions (actinic keratosis (AK) and Bowen's...
Autores principales: | Jenni, D, Karpova, MB, Mühleisen, B, Mangana, J, Dreier, J, Hafner, J, Dummer, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070204/ https://www.ncbi.nlm.nih.gov/pubmed/27843579 http://dx.doi.org/10.1136/esmoopen-2015-000003 |
Ejemplares similares
-
Expression of Metallothioneins in Cutaneous Squamous Cell Carcinoma and Actinic Keratosis
por: Zamirska, Aleksandra, et al.
Publicado: (2012) -
Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients
por: Dańczak-Pazdrowska, Aleksandra, et al.
Publicado: (2021) -
A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes
por: Wood, David L. A., et al.
Publicado: (2018) -
Serum Sialylation Changes in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Patients
por: Tampa, Mircea, et al.
Publicado: (2021) -
P21 Immunoexpression in Actinic Keratosis and Cutaneous Carcinomas
por: MARINESCU, A., et al.
Publicado: (2017)